AWGLSCP
ABG-WTT Global Life Science Capital Partners Portfolio holdings
AUM
$26.8M
This Quarter Return
+5.41%
1 Year Return
+33.61%
3 Year Return
-28.88%
5 Year Return
–
10 Year Return
–
AUM
$26.8M
AUM Growth
+$26.8M
(-30%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-46.87%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
CG Oncology
CGON
|
$12.1M |
| 2 |
Pulmonx
LUNG
|
$405K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBLL
1
CeriBell, Inc. Common Stock
CBLL
$434M
| $20.4M | 76.17% | 1,088,101 | – | – |
|
2
Rapid Micro Biosystems
RPID
$107M
| $6.38M | 23.83% | 1,848,296 | – | – |
|
|
3
CG Oncology
CGON
$2.04B
| – | – | -495,526 | Closed | -$12.1M |
|
|
4
Pulmonx
LUNG
$69.7M
| – | – | -60,204 | Closed | -$405K |
|